RemeGen Co., Ltd.

HK$70.20As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9995Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR 0.05%
Div yield —
ROE 116.54%
Biotechnology
Beta (5Y) 0.53
PE TTM 5.173
TSR TTM (22.00%)
Mkt cap HK$54.09B
ROIC 141.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$82
16.44%
(66.74%)
Sell 0|5|1|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.12
1.18
1.24
1.23
8.05%
13.40%
6.33%
5.50%
Revenue¥B
2.402
2.533
2.505
2.604
0.42%
2.86%
4.48%
10.52%
Peers (US$6.899B)
Cap (US$)
PE
5.900B
13.54x
Capital
TTM
5Y
10Y
Leveragex
5.382
0.558
0.373
EBIT/Intx
1.144
0.336
0.305
Own earn%
24.97
(109.88)
(110.75)
Sh yield%
54.86
47.97
48.91
Owners
Insiders/Inst%
3.01
36.93
Short interest%
2.07
SBC / revenue%
2.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
20–24
$1 testx
0.0
Incr. ROIC%
3